EssilorLuxottica stock (FR0000121667): new scrip dividend shares and Thai R&D hub in focus
01.06.2026 - 19:21:58 | ad-hoc-news.deEssilorLuxottica shares on Euronext Paris were in focus on Monday after the French eyewear group confirmed that 957,954 new shares will be issued as part of its 2025 scrip dividend option, adding a modest amount of equity while maintaining its policy of offering shareholders a choice between cash and stock.
According to a recent report from Reuters, EssilorLuxottica said that 957,954 new shares will be created to honor the scrip portion of its dividend, underscoring continued capital returns to investors in its home market of France and a preference by a portion of its shareholder base to reinvest in equity rather than take a full cash payout.
The stock trades under the ticker EL on Euronext Paris, which is the group’s primary listing venue and part of the French large-cap universe that is closely watched by investors tracking benchmarks such as the CAC 40 and SBF 120, even though EssilorLuxottica itself is a key player in the broader European consumer and healthcare space rather than a pure domestic French story.
The company has also been active on the strategic front, most recently highlighting on 05/18/2026 the inauguration of a new research and development hub in Thailand aimed at accelerating innovation in ophthalmic lenses and vision-care technologies, according to its investor relations website, signaling an ongoing push to deepen its footprint in fast-growing Asian markets.
For German-speaking investors, EssilorLuxottica is also accessible via secondary listings such as Xetra under the ticker ESL, giving eurozone investors outside France the possibility to trade the stock in euro through German venues while still being exposed to the same underlying French issuer.
As of: 06/01/2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: EssilorLuxottica
- Sector/industry: Eyewear, ophthalmic lenses and vision-care products
- Headquarters/country: Paris, France
- Core markets: Europe, North America, Asia-Pacific, Latin America, Middle East and Africa
- Key revenue drivers: Branded eyeglass frames and sunglasses, prescription ophthalmic lenses, retail optical chains and e-commerce distribution
- Home exchange/listing venue: Euronext Paris (EL)
- Trading currency: EUR
EssilorLuxottica: core business model
EssilorLuxottica combines large-scale design and manufacturing of lenses and frames with global wholesale and retail distribution networks, allowing the group to capture value from both premium eyewear brands and everyday vision-correction products.
What banks and research houses say about EssilorLuxottica
No verified analyst coverage was identified at the time of publication.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on EssilorLuxottica
Investors and commentators are reacting to EssilorLuxottica’s latest scrip dividend details and the opening of its Thai R&D hub, often debating how the added shares and expanded innovation footprint might influence long-term growth and earnings quality.
Conclusion
The confirmation that 957,954 new shares will be issued for EssilorLuxottica’s scrip dividend adds a specific capital-markets angle to the stock, showing the group’s willingness to keep a flexible mix between cash and equity-based shareholder returns.
At the same time, the recently announced R&D hub in Thailand underlines the company’s strategy of investing in innovation and emerging markets, which could be a relevant backdrop for how analysts and investors eventually reassess growth, margins and valuation over time.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
So schätzen die Börsenprofis EssilorLuxottica Aktien ein!
Für. Immer. Kostenlos.
